People starting nilotinib, a leukaemia drug, had a hazard ratio of 0.37 for neurodegenerative disease diagnosis or death versus matched people without chronic myeloid…People starting nilotinib, a leukaemia drug, had a hazard ratio of 0.37 for neurodegenerative disease diagnosis or death versus matched people without chronic myeloid leukaemia.
The method paired gene activity and DNA-marking measurements at about 10,000 cells per sequencing library, a collection of prepared genetic material.The method paired gene activity and DNA-marking measurements at about 10,000 cells per sequencing library, a collection of prepared genetic material.
Increasing histone 3 lysine 9 methylation reduced leukemogenesis in both young and aged murine cells.Increasing histone 3 lysine 9 methylation reduced leukemogenesis in both young and aged murine cells.